Need Physician Approval
Talzenna 0.25
5,810.60
In stock
SKU :
104102
BRCA+ PARP inhibitor therapy
Product Description
Talzenna (talazoparib) 0.25mg is a PARP inhibitor used for BRCA-mutated, HER2-negative breast cancer. It prevents cancer cell DNA repair, leading to cancer cell death.
Key Benefits
- Treats BRCA-mutated breast cancer
- PARP inhibitor therapy
- Slows cancer progression
- Oral targeted treatment
| Offer Label | Need Physician Approval |
|---|---|
| Shipping Type | Express |
Write Your Own Review
